Sign In
Buy CPIX
$5.61
-0.160 (-2.77%)
At Close: Jun 03, 2026
Cumberland Pharmaceuticals (CPIX) Q1 Earnings and Revenues Miss Estimates
10:15pm, Wednesday, 20'th May 2020
Cumberland (CPIX) delivered earnings and revenue surprises of -50.00% and -11.93%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Cumberland Q1 Adj. EPS $0.010 Misses $0.020 Estimate, Sales $9.100M Miss $9.460M Estimate
08:10pm, Wednesday, 20'th May 2020Cumberland Pharmaceuticals Reports First Quarter 2020 Financial Results & Company Update
08:05pm, Wednesday, 20'th May 2020
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology today provided a company update and announced first quarter 2020
Cumberland Pharmaceuticals, Inc. to Host Earnings Call
06:30pm, Wednesday, 20'th May 2020
NEW YORK, NY / ACCESSWIRE / May 20, 2020 / Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) will be discussing their earnings results in their 2020 First Quarter Earnings call to be held on May 20, 2020
The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test
12:00am, Wednesday, 20'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 19)
ADC Therapeutics SA (NYSE:...
Cumberland Pharmaceuticals To Announce First Quarter 2020 Financial Results
08:40pm, Friday, 15'th May 2020
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release first quarter 2020 financial results and a Company update after the market closes on Wednesday, May 20, 2020. A conf
Vibativ® Sustained Potency Confirmed In Two Surveillance Studies
08:10pm, Monday, 11'th May 2020
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a U.S. specialty pharmaceutical company announces two new publications detailing the sustained in vitro potency of Vibativ® (telavancin) as part of a 7
Analysts Estimate Cumberland Pharmaceuticals (CPIX) to Report a Decline in Earnings: What to Look Out for
04:30pm, Tuesday, 05'th May 2020
Cumberland (CPIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Cumberland Pharmaceuticals (CPIX) to Report a Decline in Earnings: What to Look Out for
12:00am, Tuesday, 05'th May 2020NCCA officials announce further postponements to summer schedule
02:21pm, Friday, 01'st May 2020
Staffordshire and Cheshire's 50-over campaigns have gone the same way as the Twenty20 Cup - but could be played later in the season
Viewray (VRAY) Receives a Hold from B.Riley FBR
11:56am, Friday, 01'st May 2020
In a report released today, Andrew D'silva from B.Riley FBR maintained a Hold rating on Viewray (VRAY), with a price target of $2.50. The company's shares
Zacks.com featured highlights include: MagnaChip Semiconductor, PJT Partners, eXp World and Cumberland Pharmaceuticals
11:04am, Friday, 01'st May 2020
Zacks.com featured highlights include: MagnaChip Semiconductor, PJT Partners, eXp World and Cumberland Pharmaceuticals
Zacks.com featured highlights include: MagnaChip Semiconductor, PJT Partners, eXp World and Cumberland Pharmaceuticals
12:00am, Friday, 01'st May 20204 Top-Ranked Liquid Bets to Build a Successful Portfolio
03:39pm, Wednesday, 29'th Apr 2020
Here are four excellent liquid stocks that can contribute to making an outstanding portfolio for yield-seeking investors.
4 Top-Ranked Liquid Bets to Build a Successful Portfolio
03:39pm, Wednesday, 29'th Apr 2020
Here are four excellent liquid stocks that can contribute to making an outstanding portfolio for yield-seeking investors.
